Mexico City /
Pfizer Mexico announced that on August 29, it submitted to the Federal Commission for Protection against Health Risks (Cofepris) the request for health registration and update of authorization for emergency use of your vaccine monovalent for covid-19 specific for the Ómicron XBB.1.5 sublineage, which is the variant with the greatest circulation worldwide currently.
Through a statement, the company highlighted that the development of this updated vaccine It was done in accordance with the recommendations of both the World Health Organization (WHO) and various regulatory authorities.
Constanza Losada, president and general director of Pfizer Mexico, emphasized that the submissions they made to the health authorities in Mexico They join those that Pfizer has carried out before other regulatory agencies internationally of the United States, approved on September 11 and Europe at the end of August.
And the company noted that other nations such as the United Kingdom, Japan and Korea also They have already made this authorization.
“We are focused on making our vaccine available, this in order to continue carrying Pfizer’s innovation to more people and not neglect the efforts that have been shown to be fundamental for the prevention of serious illness and death.”
“Likewise, we have expressed to the government of Mexico our interest in continuing the close collaboration we have had and to be included in the vaccination program that the Government of the Republic will implement in the next fall-winter season,” said the president of the company.
PMA
